Sign in Subscribe

Ionis's Olezarsen (Tryngolza) Revolutionizes Severe Hypertriglyceridemia Treatment with Unprecedented Results

Ionis's olezarsen (Tryngolza) shows "unprecedented" results for severe hypertriglyceridemia, cutting triglycerides by up to 72% and acute pancreatitis events by 85% in Phase 3 trials—a first! Favorable safety. sNDA planned by year-end.

Ionis's Olezarsen (Tryngolza) Revolutionizes Severe Hypertriglyceridemia Treatment with Unprecedented Results
Credit: Ionis Pharmaceuticals.

This post is for paying subscribers only

Already have an account? Sign in.